SB 149
7 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Browse all held record sources
Zoom to read. Drag to explore. Select a connection.
SB 149
Investigational drugs, biological products, or devices: right to try
California · Passed one chamber
Every link on this map
The same connections as a table, with the reason each one is here.
| Abbvie | Lobbied on it | Abbvie named SB 149 in 3 lobbying reports. | 3 reports |
| California Kidney Care Alliance | Lobbied on it | California Kidney Care Alliance named SB 149 in 3 lobbying reports. | 3 reports |
| Celgene Corporation | Lobbied on it | Celgene Corporation named SB 149 in 3 lobbying reports. | 3 reports |
| Edwards Lifesciences | Lobbied on it | Edwards Lifesciences named SB 149 in 3 lobbying reports. | 3 reports |
| Medtronic, Inc. | Lobbied on it | Medtronic, Inc. named SB 149 in 2 lobbying reports. | 2 reports |
| City of Murrieta | Lobbied on it | City of Murrieta named SB 149 in 2 lobbying reports. | 2 reports |
| Investigational drugs, biological products, or devices: right to try. | Source records | SB 149 has an explicit source reference to Investigational drugs, biological products, or devices: right to try.. | None |
In the news
Reporting about the selected subject. Articles are context and do not establish a connection on this map.
Loading coverage…